Accuray CEO Resigns, Board Appoints Successor
Accuray (NASDAQ: ARAY) announced today that Euan S. Thomson has resigned as President and Chief Executive Officer and Director of the Board. Accuray's Board has appointed Joshua H. Levine as his successor as President and CEO and Director of the Board, effective immediately. Thomson is anticipated to continue in a consulting role with the Company.
Thomson joined Accuray in March 2002 as CEO, was appointed President in September 2002 and served on the Board of Directors. During his tenure, Thomson expanded the radiosurgery market with the Company's flagship product, the CyberKnife System. He took the company public in February 2007 and led the company through the transformational acquisition of TomoTherapy in 2011. The acquisition of TomoTherapy added the TomoTherapy System to the Company's product portfolio, which expanded the Company into the radiation therapy market.
"I want to thank the Board, Accuray employees and customers for their support and encouragement over the last 10 years as we together changed the way people think about treating cancer patients," said Thomson. "It's been a fulfilling experience, but I feel that after being CEO for 10 years that a change in leadership